Compare PRZO & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRZO | IRIX |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1M | 20.2M |
| IPO Year | 2023 | 1996 |
| Metric | PRZO | IRIX |
|---|---|---|
| Price | $1.30 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 456.9K | 70.7K |
| Earning Date | 08-28-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,007,440.00 | ★ $50,647,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 80.42 | 4.58 |
| 52 Week Low | $0.53 | $0.78 |
| 52 Week High | $3.16 | $1.89 |
| Indicator | PRZO | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 48.87 |
| Support Level | $1.25 | $0.92 |
| Resistance Level | $1.51 | $0.98 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 17.31 | 71.10 |
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.